Journal Article Summary
This article investigates the effectiveness and safety of a combined treatment approach for primary tinnitus, which includes medication therapy and ultrasound-guided stellate ganglion block (SGB). Tinnitus is a common condition characterized by hearing sounds that are not present externally, affecting a significant number of adults and often leading to a reduced quality of life. Current treatments for tinnitus are limited and often ineffective, making the exploration of new therapeutic strategies essential for improving patient outcomes.
The study involved 113 patients diagnosed with primary tinnitus, divided into two groups: one receiving only SGB and the other receiving a combination of medication therapy and SGB. The researchers assessed various factors, including tinnitus severity, quality of life, psychological health, and patient satisfaction, before and after treatment. Results indicated that the group receiving the combined therapy experienced significantly greater improvements in tinnitus severity and psychological well-being compared to the control group, suggesting that this combined approach may be more effective than SGB alone.
However, the study has limitations, including its retrospective design, which means it can show associations but not causation. The sample size was relatively small, and the follow-up period was short, focusing on immediate outcomes rather than long-term effects. Patients should discuss these findings with their healthcare providers, considering individual treatment preferences and the potential need for further research to confirm these results and explore the long-term benefits of combined therapy for tinnitus.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Chen Zhifu, Zhang Juan, Bai Tao, Yang Peirong, Song Guochang, Yan Anjun, Wang Ruiling. Combined drug therapy with ultrasound-guided stellate ganglion block for primary tinnitus. Medicine 2026. DOI: 10.1097/MD.0000000000048044. PMID: 41861205. PMCID: PMC13008153.
Featured Pill Pals Product
B-12 Kit - Intramuscular (Cyanocobalamin B12 Injection) --- Sola Pharma
B-12 Kit – Intramuscular (Cyanocobalamin B12 Injection) — Sola Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
